Customer Guest
please type the captcha code.
Register|Generate Password|Dos and Don'ts of Demat Account
For Login related queries e-mail: emkayassist@emkayglobal.com
"Attention Investors
1. Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020. 2. Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. 3. Pay 20% upfront margin of the transaction value to trade in cash market segment. 4. Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard. 5. Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month. 6.Investor Charter 7.Disclosure of Complaints 8.COMPLAINTS / SCORES 9. Verify Nomination in Account, click on link (:: Central Depository Services (India) Limited :: )
.......... Issued in the interest of Investors"
Regenerate OTP
Please contact to emkayassist@emkayglobal.com
Please select Mobile No and Email Id for OTP
Login | Register
Login | Register|Forgot password?
As of December 2025 43.10% is owned by Promoters and 56.90% by Public. Among Promoters holding Indian Promoters holds 42.93% and Foreign Promoters ho...more...
Significant increase in volume has been observed in Aarti Pharmalabs Limited. The Exchange in order to ensure that investors have latest rel...more...
Please find attached clarifciation with respect to increase in volumemore...
The Exchange has sought clarification from Aarti Pharmalabs Ltd on January 12 2026 with reference to Movement in Volume. The reply is awaited.more...
Significant increase in volume has been observed in Aarti Pharmalabs Limited. The Exchange in order to ensure that investors have latest relevant inf...more...
Aarti Pharmalabs Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations 2018more...
Please find enclosedmore...
Aarti Pharmalabs Limited has informed the Exchange about change in Managementmore...
Aarti Pharmalabs Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Re...more...
Aarti Pharmalabs Limited has informed the Exchange about Transcriptmore...
Transcript of Q2 FY 26 Earnings Conference Call.more...
Recording of the Earnings Conference call for Q2 FY 26more...
Aarti Pharmalabs Limited has informed the Exchange about Link of Recordingmore...
Aarti Pharmalabs Limited has informed the Exchange about Copy of Newspaper Publicationmore...
Aarti Pharmalabs Limited has informed the Exchange about Investor Presentationmore...
Investor Presentation for Q2 FY 26more...
The company reported standalone net profit of Rs 30.93 crore for the quarter ended September 30 2025 as compared to Rs 47.84 crore in the sa...more...
Please find enclosed.more...
Aarti Pharmalabs Limited has submitted to the Exchange the financial results for the period ended September 30 2025.more...
BOARD MEETINGS Company Name : Latent View Analytic Date : 01-02-2026